MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$28,101K
(-28.23%↓ Y/Y)
Interest income
$9,852K
(-13.50%↓ Y/Y)
Net loss
-$24,361K
(-3.63%↓ Y/Y)
Unrealized loss on
available-for-sale securities, net
-$3,740K
(-334.78%↓ Y/Y)
Total other income
$9,852K
(-13.50%↓ Y/Y)
Loss from operations
-$34,213K
(1.96%↑ Y/Y)
Collaboration revenue
$3,733K
Total operating
expenses
$37,946K
(8.74%↑ Y/Y)
Research and development
$26,813K
(7.02%↑ Y/Y)
General and
administrative
$11,133K
(13.12%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX)